Glutamate and the glutamate receptor system:: a target for drug action

被引:98
作者
Bleich, S [1 ]
Römer, K [1 ]
Wiltfang, J [1 ]
Kornhuber, J [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany
关键词
glutamate; glutamate receptors; excitotoxicity; glutamate antagonists; neuroprotective treatment;
D O I
10.1002/gps.933
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Glutamate is the most important excitatory neurotransmitter in the central nervous system. In the process, glutamate fulfills numerous physiological functions, but also plays an important role in the pathophysiology of different neurological and psychiatric diseases, especially when an imbalance in glutamatergic neurotransmission occurs. Under certain conditions, glutamate has a toxic action resulting front an activation of specific glutamate receptors, which leads to acute or chronic death of nerve cells. Such mechanisins are currently under discussion in acute neuronal death within the context of hypoxia. ischaernia and trauinas, as well as in chronic neurodegenerative or ncuronictabolic diseases, idiopathic parkinsonian syndrome, Alzheimer's dementia and Huntington's disease. It is hoped that glutamate antagonists will lead to novel therapies for these diseases, whereby the further development of glutamate antagonists for blocking disease-specific subtypes of glutamate receptors may be of major importance in the future. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:S33 / S40
页数:8
相关论文
共 58 条
[41]   Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist -: a review of preclinical data [J].
Parsons, CG ;
Danysz, W ;
Quack, G .
NEUROPHARMACOLOGY, 1999, 38 (06) :735-767
[42]   COMPARISON OF THE POTENCY, KINETICS AND VOLTAGE-DEPENDENCY OF A SERIES OF UNCOMPETITIVE NMDA RECEPTOR ANTAGONISTS IN-VITRO WITH ANTICONVULSIVE AND MOTOR IMPAIRMENT ACTIVITY IN-VIVO [J].
PARSONS, CG ;
QUACK, G ;
BRESINK, I ;
BARAN, L ;
PRZEGALINSKI, E ;
KOSTOWSKI, W ;
KRZASCIK, P ;
HARTMANN, S ;
DANYSZ, W .
NEUROPHARMACOLOGY, 1995, 34 (10) :1239-1258
[43]   Glutamate in CNS disorders as a target for drug development: An update [J].
Parsons, CG ;
Danysz, W ;
Quack, G .
DRUG NEWS & PERSPECTIVES, 1998, 11 (09) :523-569
[44]  
PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G
[45]  
Rao VLR, 2001, BRAIN RES, V911, P96
[46]   PHARMACOTOXIC PSYCHOSIS AFTER MEMANTINE IN PARKINSONS-DISEASE [J].
RIEDERER, P ;
LANGE, KW ;
KORNHUBER, J ;
DANIELCZYK, W .
LANCET, 1991, 338 (8773) :1022-1023
[47]   The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest:: A study in the chronic porcine model [J].
Rimpiläinen, J ;
Pokela, M ;
Kiviluoma, K ;
Vainionpää, V ;
Hirvonen, J ;
Ohtonen, P ;
Jäntti, V ;
Anttila, V ;
Heinone, H ;
Juvonen, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (05) :957-968
[48]   EXCITOTOXICITY AND THE NMDA RECEPTOR [J].
ROTHMAN, SM ;
OLNEY, JW .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :299-302
[49]   THE NMDA RECEPTOR COMPLEX [J].
SCATTON, B .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (08) :389-400
[50]   THE TINS TIPS LECTURE - THE MOLECULAR-BIOLOGY OF MAMMALIAN GLUTAMATE-RECEPTOR CHANNELS [J].
SEEBURG, PH .
TRENDS IN NEUROSCIENCES, 1993, 16 (09) :359-365